U.S. Markets closed
  • S&P Futures

    4,163.75
    +8.25 (+0.20%)
     
  • Dow Futures

    34,042.00
    +84.00 (+0.25%)
     
  • Nasdaq Futures

    13,919.25
    +22.00 (+0.16%)
     
  • Russell 2000 Futures

    2,232.00
    +2.70 (+0.12%)
     
  • Crude Oil

    63.69
    +0.31 (+0.49%)
     
  • Gold

    1,769.10
    -1.50 (-0.08%)
     
  • Silver

    25.84
    +0.01 (+0.03%)
     
  • EUR/USD

    1.2051
    +0.0010 (+0.0844%)
     
  • 10-Yr Bond

    1.6010
    +0.0280 (+1.78%)
     
  • Vix

    17.29
    +1.04 (+6.40%)
     
  • GBP/USD

    1.3995
    +0.0011 (+0.0812%)
     
  • USD/JPY

    108.2410
    +0.0910 (+0.0841%)
     
  • BTC-USD

    54,778.61
    -2,129.66 (-3.74%)
     
  • CMC Crypto 200

    1,225.62
    -73.33 (-5.65%)
     
  • FTSE 100

    7,000.08
    -19.45 (-0.28%)
     
  • Nikkei 225

    29,139.52
    -545.85 (-1.84%)
     

New Strong Buy Stocks for January 30th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Tirthankar Chakraborty
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Arcosa, Inc. (ACA): This company that manufactures and sells infrastructure-related products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Arcosa, Inc. Price and Consensus

 

Arcosa, Inc. Price and Consensus
Arcosa, Inc. Price and Consensus

Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote

Sculptor Capital Management, Inc. (SCU): This publicly owned hedge fund sponsor has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Sculptor Capital Management Price and Consensus

 

Och-Ziff Capital Management Group LLC Price and Consensus
Och-Ziff Capital Management Group LLC Price and Consensus

Sculptor Capital Management price-consensus-chart | Sculptor Capital Management Quote

Sibanye Gold Limited (SBGL): This company that operates as a precious metals mining company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.1% over the last 90 days.

Sibanye Gold Limited Price and Consensus

 

Sibanye Gold Limited Price and Consensus
Sibanye Gold Limited Price and Consensus

Sibanye Gold Limited price-consensus-chart | Sibanye Gold Limited Quote

Vector Group Ltd. (VGR): This company that manufactures and sells cigarettes in the United States has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Vector Group Ltd. Price and Consensus

 

Vector Group Ltd. Price and Consensus
Vector Group Ltd. Price and Consensus

Vector Group Ltd. price-consensus-chart | Vector Group Ltd. Quote

Independent Bank Group, Inc. (IBTX): This company that provides various commercial banking products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.

Independent Bank Group, Inc Price and Consensus

 

Independent Bank Group, Inc Price and Consensus
Independent Bank Group, Inc Price and Consensus

Independent Bank Group, Inc price-consensus-chart | Independent Bank Group, Inc Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Vector Group Ltd. (VGR) : Free Stock Analysis Report
 
Och-Ziff Capital Management Group LLC (SCU) : Free Stock Analysis Report
 
Sibanye Gold Limited (SBGL) : Free Stock Analysis Report
 
Independent Bank Group, Inc (IBTX) : Free Stock Analysis Report
 
Arcosa, Inc. (ACA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research